360Dx

U. of Utah, Intermountain Win $3.8M Grant to Develop Cancer Risk Management Platform

Sep 01, 2017

NEW YORK (360Dx) – A team of researchers from the University of Utah, Intermountain Healthcare, and the Huntsman Cancer Institute have received a five-year, $3.8 million grant from the National Cancer Institute to develop a platform for personalized cancer risk management.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

U. of Utah, Intermountain Win $3.8M Grant to Develop Cancer Risk Management Platform

To read the full story....

Breaking News

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

Biovica Files FDA 510(k) Submission for Breast Cancer Treatment Response Assay

Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

What's Popular?

Natera Cancer Liquid Biopsy Test Coverage to Expand Under New Draft LCD

Biovica Files FDA 510(k) Submission for Breast Cancer Treatment Response Assay

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Sponsorships